Skip to content

Treatment effect of peripheral magnetic stimulation in patients with neck myofascial pain syndrome: A randomized, sham controlled, crossover trial

Treatment effect of peripheral magnetic stimulation in patients with neck myofascial pain syndrome: A randomized, sham controlled, crossover trial

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20241110004
Enrollment
27
Registered
2024-11-10
Start date
2024-11-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myofascial pain syndrome of the neck. Peripheral Magnetic Stimulation, myofascial pain syndrome, neck pain

Interventions

PMS used the Salus Talent Pro model from REMED Rehabilitation Medical Company. The treatment targets the pain area for a total of 10 minutes with the following settings: Scan phase: Frequency of 5 Hz
Experimental Device,Placebo Comparator Device
Peripheral Magnetic Stimulation (PMS),sham group

Sponsors

Thabo crown prince hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed by a physician with MPS at neck, active myofascial pain trigger points according to Simon's diagnostic criteria. 2.Age between 18 and 60 years old. 3.Pain level of VAS (Visual Analog Scale) greater than or equal to 40. 5.Never received PMS treatment before.

Exclusion criteria

Exclusion criteria: 1.Cervical bone abnormalities or joint diseases, or cervical bone injuries, such as ankylosing spondylitis, cervical spondylolisthesis, or rheumatoid arthritis 2.Previously undergone cervical bone surgery 3.Neurological disorders, such as radiculopathy, myelopathy, or neuropathy 4.Pregnant or breastfeeding women 5.Implanted electronic or metal devices, such as cardiac pacemakers or aneurysm clips 6.Cancer or tumors in the neck region 7.Coagulopathy 8.Psychiatric disorders, such as depression

Design outcomes

Primary

MeasureTime frame
Primary Outcome: Pain level assessed by the Visual Analog Scale (VAS). at after of the intervention Pain levels will be assessed through interviews using the Visual Analog Scale (VAS), which ranges from 0 to 100 points

Secondary

MeasureTime frame
Secondary Outcome: Neck Disability Index (NDI) in Thai version, assessing neck pain-related disability.The amount of pain medication (Diclofenac) consumed. at after of the intervention NDI is used to assess disability related to neck pain. It consists of 10 items, with a total score ranging from 0 to 50. Each item has sub-scores from 0 to 5

Countries

Thailand

Contacts

Public ContactThapanun Mahisanun

Thabo crown prince hospital

thabohospital.nk@gmail.com042431015

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026